pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • GALLIFREY
    GALLIFREY (NORETHINDRONE ACETATE)
    no indication XIROMED
  • GASTROGRAFIN
    GASTROGRAFIN (DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM)
    no indication BRACCO
  • GAVILYTE-N
    GAVILYTE-N (POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE)
    no indication NOVEL LABS INC
  • Preclinical
    GB-13
    Pediatric Diffuse Intrinsic Pontine Glioma
← prev
page 87 of 231
next →
131
Pain89
Neurology1
Targepeutics Inc
  • Preclinical
    GB-264
    Gastrointestinal Tumor Genor BioPharma Co Ltd
  • Preclinical
    GB-266
    Unspecified Cancer Genor BioPharma Co Ltd
  • Preclinical
    GB-910
    Rheumatoid Arthritis Gbiologics Inc
  • Phase 1
    GC-1130A
    Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) GC Biopharma Corp
  • Phase 2
    GC-1134A
    Fabry Disease GC Biopharma Corp
  • Preclinical
    GC-376
    Coronavirus Disease 2019 (COVID-19) Anivive Lifesciences Inc
  • Phase 3
    GC-5107D
    Primary Humoral Immune Deficiencies GC Biopharma Corp
  • Preclinical
    GCC-2004
    B-Cell Non-Hodgkin Lymphoma$ARTV Artiva Biotherapeutics, Inc.
  • Phase 2
    GCC-4001
    Idiopathic Inflammatory Myopathy (IIM)$ARTV Artiva Biotherapeutics, Inc.
  • Phase 2
    GD2-SADA-177Lu-Proteus
    Melanoma Y-mAbs Therapeutics Inc
  • Preclinical
    GDT-002
    Pancreatic Ductal Adenocarcinoma Guidant Biotherapeutics Corp
  • GENTAMICIN
    GENTAMICIN
    no indication FRESENIUS KABI USA
  • Preclinical
    GENV-HEM
    Hemophilia A (Factor VIII Deficiency) GeneVentiv Therapeutics Inc
  • Preclinical
    GEO-EM01-Z
    Ebolavirus Infections (Ebola Hemorrhagic Fever)$GOVX GeoVax Labs, Inc.
  • Preclinical
    GEO-MVA
    Monkeypox$GOVX GeoVax Labs, Inc.
  • Preclinical
    GEO-MVA-MUC1
    Breast Cancer$GOVX GeoVax Labs, Inc.
  • Phase 2
    GEOCM-04S1
    Coronavirus Disease 2019 (COVID-19)$GOVX GeoVax Labs, Inc.
  • Preclinical
    GEOEM-01S
    Ebolavirus Infections (Ebola Hemorrhagic Fever)$GOVX GeoVax Labs, Inc.
  • Preclinical
    GEOMM-01
    Marburgvirus Infections (Marburg Hemorrhagic Fever)$GOVX GeoVax Labs, Inc.
  • Preclinical
    GEOZM-02
    Zika Virus Infections$GOVX GeoVax Labs, Inc.
  • Preclinical
    GF-103
    Wet (Neovascular / Exudative) Macular Degeneration HLB Genex Inc
  • Phase 2
    GFH-375
    Colorectal Cancer$VSTM Verastem, Inc.
  • Preclinical
    GH-3595
    Solid Tumor Suzhou GenHouse Pharmaceutical Co Ltd
  • Phase 2
    GI-102
    Metastatic Melanoma GI Innovation Co Ltd
  • Phase 1
    GIGA-2339
    Hepatitis B$GRFS Grifols SA
  • Phase 1
    GIGA-564
    Solid Tumor GigaGen Inc